CFIUS stalls Chinese takeover of cancer treatment provider
Shutterstock/CI Photos
The Committee on Foreign Investment in the US has issued an interim order temporarily blocking a Sino Biopharm subsidiary’s $161 million acquisition of a biopharmaceutical company.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10